Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report)'s share price reached a new 52-week high on Monday . The company traded as high as $35.46 and last traded at $34.97, with a volume of 529 shares traded. The stock had previously closed at $34.58.
Wall Street Analyst Weigh In
Several analysts have issued reports on the stock. UBS Group initiated coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective for the company. JMP Securities reissued a "market outperform" rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. JPMorgan Chase & Co. upped their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and an average price target of $33.00.
View Our Latest Report on Option Care Health
Option Care Health Trading Down 0.4 %
The firm has a market capitalization of $5.76 billion, a P/E ratio of 29.41, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The stock has a 50-day simple moving average of $32.36 and a two-hundred day simple moving average of $28.42. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.
Insider Buying and Selling
In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is owned by insiders.
Hedge Funds Weigh In On Option Care Health
A number of hedge funds and other institutional investors have recently modified their holdings of OPCH. Murphy & Mullick Capital Management Corp purchased a new stake in Option Care Health during the fourth quarter worth $26,000. UMB Bank n.a. increased its holdings in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC raised its position in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after acquiring an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC lifted its stake in shares of Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Public Employees Retirement System of Ohio lifted its stake in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after purchasing an additional 332 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.
Option Care Health Company Profile
(
Get Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
